Pediatric tuina for the treatment of anorexia in children under 14 years: a systematic review and meta-analysis of randomized controlled trials.

Anorexia Meta-Analysis Pediatric tuina Randomized controlled trial Systematic review Traditional Chinese medicine

Journal

Complementary therapies in medicine
ISSN: 1873-6963
Titre abrégé: Complement Ther Med
Pays: Scotland
ID NLM: 9308777

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 20 11 2019
revised: 18 03 2020
accepted: 13 04 2020
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 3 11 2020
Statut: ppublish

Résumé

Pediatric tuina is used to prevent and treat disease by employing various manipulative techniques on specific parts of the body, appropriate to the child's specific physiological and pathological characteristics. To evaluate the effects and safety of pediatric tuina as a non-pharmaceutical therapy for anorexia in children under 14 years. Randomized controlled trials (RCTs) comparing pediatric tuina with medicine for anorexia were included in this review. Six electronic databases were searched from inception to June 2019. Two authors independently extracted data and assessed the risk of bias. Significant effective rate (defined as appetite improved and food intake returning to 3/4 or more of normal intake) was used as primary outcome. Secondary outcomes included food intake, compliance and adverse events. Trial sequential analysis (TSA) was used to calculate the required information size in a meta-analysis and to detect the robustness of the results. Certainty of the evidence was assessed using the online GRADEpro tool. Of the included 28 RCTs involving 2650 children, the majority had a high or unclear risk of bias in terms of allocation concealment, blinding, and selective reporting. All trials compared tuina with western medicine or Chinese herbs. For significant effective rate, meta-analysis showed that tuina was superior to western medicine (risk ratio (RR) 1.68, 95 % confidence interval (CI) [1.35, 2.08]) and Chinese herbs (RR 1.36, 95 % CI [1.19, 1.55]). For food intake, 9 trials evaluated it in the form of score (1 points, 2 points, 4 points and 6 points) calculated according to the reduction degree of food intake. Six points represented the most serious. Meta-analysis showed tuina was superior to western medicine (mean difference (MD) -0.88, 95 % CI [-1.27, -0.50]) and Chinese herbs (MD -0.69, 95 % CI [-1.00, -0.38]) on lightening the reduction degree of food intake. Two trials reported compliance and six trials reported no adverse events occurred in pediatric tuina group. TSA for significant effective rate demonstrated that the pooled data had insufficient power regarding both numbers of trials and participants. Low certainty of evidence suggested pediatric tuina was beneficial and safe for the treatment of anorexia in children under 14 years. Furthermore well-designed RCTs with adequate sample sizes are needed.

Sections du résumé

BACKGROUND BACKGROUND
Pediatric tuina is used to prevent and treat disease by employing various manipulative techniques on specific parts of the body, appropriate to the child's specific physiological and pathological characteristics.
OBJECTIVE OBJECTIVE
To evaluate the effects and safety of pediatric tuina as a non-pharmaceutical therapy for anorexia in children under 14 years.
METHODS METHODS
Randomized controlled trials (RCTs) comparing pediatric tuina with medicine for anorexia were included in this review. Six electronic databases were searched from inception to June 2019. Two authors independently extracted data and assessed the risk of bias. Significant effective rate (defined as appetite improved and food intake returning to 3/4 or more of normal intake) was used as primary outcome. Secondary outcomes included food intake, compliance and adverse events. Trial sequential analysis (TSA) was used to calculate the required information size in a meta-analysis and to detect the robustness of the results. Certainty of the evidence was assessed using the online GRADEpro tool.
RESULTS RESULTS
Of the included 28 RCTs involving 2650 children, the majority had a high or unclear risk of bias in terms of allocation concealment, blinding, and selective reporting. All trials compared tuina with western medicine or Chinese herbs. For significant effective rate, meta-analysis showed that tuina was superior to western medicine (risk ratio (RR) 1.68, 95 % confidence interval (CI) [1.35, 2.08]) and Chinese herbs (RR 1.36, 95 % CI [1.19, 1.55]). For food intake, 9 trials evaluated it in the form of score (1 points, 2 points, 4 points and 6 points) calculated according to the reduction degree of food intake. Six points represented the most serious. Meta-analysis showed tuina was superior to western medicine (mean difference (MD) -0.88, 95 % CI [-1.27, -0.50]) and Chinese herbs (MD -0.69, 95 % CI [-1.00, -0.38]) on lightening the reduction degree of food intake. Two trials reported compliance and six trials reported no adverse events occurred in pediatric tuina group. TSA for significant effective rate demonstrated that the pooled data had insufficient power regarding both numbers of trials and participants.
CONCLUSIONS CONCLUSIONS
Low certainty of evidence suggested pediatric tuina was beneficial and safe for the treatment of anorexia in children under 14 years. Furthermore well-designed RCTs with adequate sample sizes are needed.

Identifiants

pubmed: 32507428
pii: S0965-2299(19)31780-7
doi: 10.1016/j.ctim.2020.102411
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102411

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Shi-Bing Liang (SB)

Centre for Evidence-Based Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China; School of Basic Medicine, Shanxi University of Chinese Medicine, Taiyuan, 030000, China. Electronic address: zyi20126185@163.com.

Bao-Yong Lai (BY)

The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: baoyonglai@bucm.edu.cn.

Hui-Juan Cao (HJ)

Centre for Evidence-Based Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: huijuancao327@hotmail.com.

Qiu-Han Cai (QH)

Clinical Trial Center, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China. Electronic address: happyqiuhan@126.com.

Xue Bai (X)

Centre for Evidence-Based Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: 20170931127@bucm.edu.cn.

Jing Li (J)

Centre for Evidence-Based Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: lj@bucm.edu.cn.

Ya-Peng Zhang (YP)

Centre for Evidence-Based Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: zhangyapeng@bucm.edu.cn.

Yuan Chi (Y)

Centre for Evidence-Based Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: chiyuan0717@163.com.

Nicola Robinson (N)

School of Health and Social Care, London South Bank University, London, SE1 0AA, UK; Centre for Evidence-Based Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: nicky.robinson@lsbu.ac.uk.

Jian-Ping Liu (JP)

Centre for Evidence-Based Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China; Institute of Integrated Traditional Chinese Medicine and Western Medicine, Guangzhou Medical University, Guangzhou, China; National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of Health Science, UiT, The Arctic University of Norway, 9037 Tromsø, Norway. Electronic address: Liujp@bucm.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH